{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:28:02Z","timestamp":1771644482904,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PI14\/00005"],"award-info":[{"award-number":["PI14\/00005"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PI14\/00070"],"award-info":[{"award-number":["PI14\/00070"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PI17\/00021"],"award-info":[{"award-number":["PI17\/00021"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PI17\/00166"],"award-info":[{"award-number":["PI17\/00166"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Departamento de Ciencia, Tecnolog\u00eda y Universidad del Gobierno de Arag\u00f3n"},{"name":"FEDER Funding Program from the European Union"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.drudis.2018.01.031","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T14:15:21Z","timestamp":1515680121000},"page":"493-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Increasing mtDNA levels as therapy for mitochondrial optic neuropathies"],"prefix":"10.1016","volume":"23","author":[{"given":"Eduardo","family":"Ruiz-Pesini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Emperador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"L\u00f3pez-Gallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Hern\u00e1ndez-Ainsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2018.01.031_bib0005","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/bjo.2003.027664","article-title":"The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head","volume":"88","author":"Barron","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.drudis.2018.01.031_bib0010","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bbabio.2008.09.003","article-title":"20 years of human mtDNA pathologic point mutations: carefully reading the pathogenicity criteria","volume":"1787","author":"Montoya","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2018.01.031_bib0015","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00401-016-1625-2","article-title":"A neurodegenerative perspective on mitochondrial optic neuropathies","volume":"132","author":"Yu-Wai-Man","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.drudis.2018.01.031_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140919","article-title":"Measurement of systemic mitochondrial function in advanced primary open-angle glaucoma and Leber hereditary optic neuropathy","volume":"10","author":"Van Bergen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2018.01.031_bib0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/164_2017_2","article-title":"Leber hereditary optic neuropathy: exemplar of an mtDNA disease","volume":"240","author":"Wallace","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.drudis.2018.01.031_bib0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1086\/519394","article-title":"Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background","volume":"81","author":"Hudson","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.drudis.2018.01.031_bib0035","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awv216","article-title":"Mitochondrial DNA copy number differentiates the Leber\u2019s hereditary optic neuropathy affected individuals from the unaffected mutation carriers","volume":"139","author":"Bianco","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.drudis.2018.01.031_bib0040","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/brain\/awp158","article-title":"Gene-environment interactions in Leber hereditary optic neuropathy","volume":"132","author":"Kirkman","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.drudis.2018.01.031_bib0045","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sj.eye.6700362","article-title":"Leber\u2019s hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virus","volume":"17","author":"Mackey","year":"2003","journal-title":"Eye"},{"key":"10.1016\/j.drudis.2018.01.031_bib0050","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2174\/1381612823666170125164856","article-title":"Treatment of Leber\u2019s hereditary optic neuropathy","volume":"23","author":"Karanjia","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drudis.2018.01.031_bib0055","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","article-title":"Glaucoma","volume":"390","author":"Jonas","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2018.01.031_bib0060","series-title":"Glaucoma, Open Angle","author":"Foris","year":"2017"},{"key":"10.1016\/j.drudis.2018.01.031_bib0065","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1167\/iovs.05-1639","article-title":"Mitochondrial abnormalities in patients with primary open-angle glaucoma","volume":"47","author":"Abu-Amero","year":"2006","journal-title":"Invest. Ophthalmol.Vis. Sci."},{"key":"10.1016\/j.drudis.2018.01.031_bib0070","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1167\/iovs.12-9596","article-title":"Impaired complex-I-linked respiration and ATP synthesis in primary open-angle glaucoma patient lymphoblasts","volume":"53","author":"Lee","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2018.01.031_bib0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nbd.2015.05.012","article-title":"Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency","volume":"82","author":"Lascaratos","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.drudis.2018.01.031_bib0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s10384-005-0290-0","article-title":"Mitochondrial DNA mutations with Leber\u2019s hereditary optic neuropathy in Japanese patients with open-angle glaucoma","volume":"50","author":"Inagaki","year":"2006","journal-title":"Jpn. J Ophthalmol."},{"key":"10.1016\/j.drudis.2018.01.031_bib0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10792-012-9623-4","article-title":"Glaucoma progression associated with Leber\u2019s hereditary optic neuropathy","volume":"33","author":"Nucci","year":"2013","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.drudis.2018.01.031_bib0090","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/EBC20160090","article-title":"Origins of mtDNA mutations in ageing","volume":"61","author":"Szczepanowska","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.drudis.2018.01.031_bib0095","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.drudis.2018.01.031_bib0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nbd.2014.11.014","article-title":"Cumulative mtDNA damage and mutations contribute to the progressive loss of RGCs in a rat model of glaucoma","volume":"74","author":"Wu","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.drudis.2018.01.031_bib0105","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archopht.1977.04450040064007","article-title":"Family history in primary open-angle glaucoma","volume":"95","author":"Shin","year":"1977","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.drudis.2018.01.031_bib0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/09286589409047221","article-title":"Genetic risk factor in primary open-angle glaucoma: a case-control study","volume":"1","author":"Charliat","year":"1994","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.drudis.2018.01.031_bib0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/09286589609080119","article-title":"Analyses of reported family history of glaucoma: a preliminary investigation: The Barbados Eye Study Group","volume":"3","author":"Nemesure","year":"1996","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.drudis.2018.01.031_bib0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1076\/opep.9.5.333.10335","article-title":"Bias in self-reported family history and relationship to glaucoma: the Blue Mountains Eye Study","volume":"9","author":"Mitchell","year":"2002","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.drudis.2018.01.031_bib0125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1167\/iovs.13-13020","article-title":"Results of a patient-directed survey on frequency of family history of glaucoma in 2170 patients","volume":"55","author":"Gramer","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2018.01.031_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070760","article-title":"Mitochondrial genome analysis of primary open angle glaucoma patients","volume":"8","author":"Banerjee","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2018.01.031_bib0135","first-page":"1468","article-title":"Mitochondrial DNA lineages of African origin confer susceptibility to primary open-angle glaucoma in Saudi patients","volume":"17","author":"Abu-Amero","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.drudis.2018.01.031_bib0140","first-page":"454","article-title":"Association of primary open-angle glaucoma with mitochondrial variants and haplogroups common in African Americans","volume":"22","author":"Collins","year":"2016","journal-title":"Mol. Vis."},{"key":"10.1016\/j.drudis.2018.01.031_bib0145","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1167\/iovs.06-0299","article-title":"Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis","volume":"47","author":"Rudnicka","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2018.01.031_bib0150","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10792-016-0245-0","article-title":"The association between cigarette smoking and primary open-angle glaucoma: a systematic review","volume":"37","author":"Jain","year":"2017","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.drudis.2018.01.031_bib0155","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1177\/112067210601600511","article-title":"Changing patterns of ocular manifestations in HIV seropositive patients treated with HAART","volume":"16","author":"Accorinti","year":"2006","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.drudis.2018.01.031_bib0160","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/brain\/awq276","article-title":"Oestrogens ameliorate mitochondrial dysfunction in Leber\u2019s hereditary optic neuropathy","volume":"134","author":"Giordano","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.drudis.2018.01.031_bib0165","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/08820538.2015.1114845","article-title":"Is estrogen a therapeutic target for glaucoma?","volume":"31","author":"Dewundara","year":"2016","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.drudis.2018.01.031_bib0170","first-page":"138","article-title":"Correlates of peripheral blood mitochondrial DNA content in a general population","volume":"183","author":"Knez","year":"2016","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drudis.2018.01.031_bib0175","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/sj.bjc.6601838","article-title":"Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma","volume":"90","author":"Yin","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drudis.2018.01.031_bib0180","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbadis.2012.04.014","article-title":"Oxidative phosphorylation differences between mitochondrial DNA haplogroups modify the risk of Leber\u2019s hereditary optic neuropathy","volume":"1822","author":"Gomez-Duran","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2018.01.031_bib0185","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.364","article-title":"Cigarette toxicity triggers Leber\u2019s hereditary optic neuropathy by affecting mtDNA copy number, oxidative phosphorylation and ROS detoxification pathways","volume":"6","author":"Giordano","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drudis.2018.01.031_bib0190","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MOP.0000000000000193","article-title":"Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy","volume":"27","author":"Poirier","year":"2015","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.drudis.2018.01.031_bib0195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neulet.2014.12.004","article-title":"Long-term evaluation of Leber\u2019s hereditary optic neuropathy-like symptoms in rotenone administered rats","volume":"585","author":"Zhang","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drudis.2018.01.031_bib0200","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40478-016-0346-z","article-title":"The retina as an early biomarker of neurodegeneration in a rotenone\u2013induced model of Parkinson\u2019s disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain","volume":"4","author":"Normando","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.drudis.2018.01.031_bib0205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/17460441.2017.1281244","article-title":"Rodent models of glaucoma and their applicability for drug discovery","volume":"12","author":"Agarwal","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.drudis.2018.01.031_bib0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/02713683.2015.1004719","article-title":"Riluzole- and resveratrol-induced delay of retinal ganglion cell death in an experimental model of glaucoma","volume":"41","author":"Pirhan","year":"2016","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.drudis.2018.01.031_bib0215","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/OPX.0000000000000991","article-title":"Vision Recovery despite retinal ganglion cell loss in Leber\u2019s hereditary optic neuropathy","volume":"93","author":"Webber","year":"2016","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.drudis.2018.01.031_bib0220","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/eye.2016.281","article-title":"Targeting retinal ganglion cell recovery","volume":"31","author":"Crowston","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.drudis.2018.01.031_bib0225","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0042-6989(97)00444-6","article-title":"Leber hereditary optic neuropathy: respiratory chain dysfunction and degeneration of the optic nerve","volume":"38","author":"Howell","year":"1998","journal-title":"Vision Res."},{"key":"10.1016\/j.drudis.2018.01.031_bib0230","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/01658107.2016.1213860","article-title":"Leber hereditary optic neuropathy with interval of visual loss greater than 12 months","volume":"40","author":"Prado","year":"2016","journal-title":"Neuroophthalmology"},{"key":"10.1016\/j.drudis.2018.01.031_bib0235","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/WNO.0000000000000346","article-title":"Atypical Leber hereditary optic neuropathy: 18 year interval between eyes","volume":"36","author":"Ohden","year":"2016","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.drudis.2018.01.031_bib0240","doi-asserted-by":"crossref","first-page":"16067","DOI":"10.1038\/nrdp.2016.67","article-title":"Primary open-angle glaucoma","volume":"2","author":"Weinreb","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.drudis.2018.01.031_bib0245","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pharmthera.2016.06.004","article-title":"Emerging mitochondrial therapeutic targets in optic neuropathies","volume":"165","author":"Lopez Sanchez","year":"2016","journal-title":"Pharmacol. Ther."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644617304713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644617304713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:36:35Z","timestamp":1761222995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644617304713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1359644617304713"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2018.01.031","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing mtDNA levels as therapy for mitochondrial optic neuropathies","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2018.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}